000 | 00992 a2200265 4500 | ||
---|---|---|---|
005 | 20250514042113.0 | ||
264 | 0 | _c20021016 | |
008 | 200210s 0 0 eng d | ||
022 | _a0006-3223 | ||
024 | 7 |
_a10.1016/s0006-3223(01)01353-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScolnick, Edward M | |
245 | 0 | 0 |
_aDiscovery and development of antidepressants: a perspective from a pharmaceutical discovery company. _h[electronic resource] |
260 |
_bBiological psychiatry _cAug 2002 |
||
300 |
_a154-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntidepressive Agents _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xmetabolism |
650 | 0 | 4 | _aDrug Industry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
773 | 0 |
_tBiological psychiatry _gvol. 52 _gno. 3 _gp. 154-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0006-3223(01)01353-1 _zAvailable from publisher's website |
999 |
_c12065346 _d12065346 |